People only fool themselves Sav.
So far there is no single cure for HCV. It is at best twin therapy. BIT is twice a day and would be, at best an adjunct in a minimum of cases with another DAA which should be once a day. However the payers are revolting and writing scripts for cheaper and far less effective regimes than Harvoni. That is BITs target. BIT would be a twice a day addition to a single regime. It's market is limited in HCV and being covered better by the day. Regulus has actually, recently cured one patient with a single injection and will soon have results out for higher doses. RG-101 is pangenotype. That might upset the apple cart a BIT. But.... As I showed in the link I posted last week, the market is changing and a price war looms. So do one shot treatments etc. but payers will have a wide range of combos to choose from.
Where to for HIV, where to for 314? Need money.
A partner for the US trial, in order to save money on expensive drugs, will be of the most interest. The alternative is dilution, lots of it.
- Forums
- ASX - By Stock
- BIT
- Idenix
Idenix, page-20
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.85M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.2¢ | $8.562K | 389.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 228 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 1991719 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 228 | 0.022 |
5 | 507857 | 0.021 |
11 | 966273 | 0.020 |
10 | 1806701 | 0.019 |
10 | 1719892 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 1991719 | 1 |
0.024 | 234999 | 2 |
0.025 | 150000 | 1 |
0.026 | 53847 | 1 |
0.027 | 169508 | 3 |
Last trade - 14.47pm 18/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |